Pfizer representitive's full hearing in the special COVID committee of the European Parliament

After Pfizer CEO Albert Bourla refused to show and answer questions in front of the special COVID committee of the European Parliament, Janine Small, president of Pfizer's International Developed Markets, took his place in the hearing that took place on October 10, 2022.

She received many questions from the committee members, which, in majority, she did not specifically answer.

When asked about the "redacted" version of the contract, she said that they can't disclose the whole contract because they have interests to protect.

When asked if they tested if their injections are stopping the transmission of the virus, she said that they did not.